CD8A and neoplasm: Notably, higher expression of PD-1 and lymphocyte-activation gene 3 (LAG3), as well as lower expression of CD28 and CD127, were commonly found in tumor-infiltrating CD8+ T cells of HBV-related HCC patients (30–32).